In this study, TSC1 and TSC2 disease percentages were rather similar (46% vs 54%), but detection of mutations proved more effective in patients having definite TSC (85%) than in patients having a possible TSC diagnosis (29%). The gene discussed is TSC2; the disease is tuberous sclerosis.